Alendronate Improves Screw Fixation in Osteoporotic Bone

Moroni, Antonio; Faldini, Cesare; Hoang-Kim, Amy; Pegreffi, Francesco; Giannini, Sandro
January 2007
Journal of Bone & Joint Surgery, American Volume;Jan2007, Vol. 89-A Issue 1, p96
Academic Journal
Background: Animal studies have demonstrated the efficacy of the use of bisphosphonates to enhance screw fixation in bone. In this prospective, randomized study of pertrochanteric fractures treated with external fixation, we tested whether systemic administration of bisphosphonates would improve the fixation of hydroxyapatite-coated screws implanted in osteoporotic bone. Methods: Sixteen consecutive patients with a pertrochanteric fracture were selected. Inclusion criteria were female gender, an age of at least sixty-five years, and a bone mineral density 1-score of less than -2.5 standard deviations. Exclusion criteria included bisphosphonate treatment during the two-year period prior to the fracture. Fractures were fixed with a pertrochanteric fixator and four hydroxyapatite-coated pins. Two pins were implanted in the femoral head (pin positions 1 and 2), and two were placed in the femoral diaphysis (pin positions 3 and 4). The patients were randomized either to therapy with alendronate for a three-month postoperative period (Group A) or to no therapy (Group B). The Group-A patients received an oral dose of 70 mg of alendronate per week. The fixators were removed after three months. Results: All of the fractures healed, and no loss of reduction, nonunion, or delayed union was observed. The combined mean extraction torque (and standard deviation) of the pins implanted at positions 1 and 2 (cancellous bone) was 2558 ± 1103 N/mm in Group A and 1171 ± 480 N/mm in Group B (p < 0.0005). The combined mean extraction torque of the pins implanted at positions 3 and 4 (cortical bone) was 4327 ± 1720 N/mm in Group A and 4075 ± 1022 N/mm in Group B. Conclusions: These data show that weekly systemic administration of alendronate improves pin fixation in cancellous bone in elderly female patients with osteoporosis. We observed a twofold increase in extraction torque with the pins implanted in cancellous bone. These results support the use of alendronate in the treatment of osteoporotic pertrochanteric fractures to improve screw fixation in the femoral head.


Related Articles

  • The Ilizarov Ring External Fixator in Complex Open Fractures of the Tibia. Hasankhani, Ebrahim; Payvandi, Mahamad; Birjandinejad, Ali // European Journal of Trauma;Feb2006, Vol. 32 Issue 1, p63 

    Introduction: Complex open fracture of the tibia particularly with bone defect and infection is one of the major problems in orthopedic surgery. There are many available alternatives in the management of these fractures. Aim: The purpose of this study is to evaluate the results and efficacy of...

  • Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. Hodsman, Anthony B.; Hanley, David A.; Josse, Robert // CMAJ: Canadian Medical Association Journal;5/28/2002, Vol. 166 Issue 11, p1426 

    Discusses whether bisphosphonates reduce the risk of osteoporotic fractures. Mortality from bone fractures in the elderly; Fracture rates among patients with osteoporosis; Indication that bisphosphonates increase bone mineral density; Expected reduction in morbidity and mortality.

  • Who should have bisphosphonates? Woolf, Tony // Pulse;5/31/2004, Vol. 64 Issue 22, p60 

    Provides some insights into the use of bisphosphonates. Effectiveness in preventing fractures; Risk factors and indications; Osteoporosis; Diagnosis and treatment.

  • Osteoporosis.  // Current Medical Literature: Rheumatology;2008, Vol. 27 Issue 1, p21 

    The article discusses research being done on the use of a case manager to improve osteoporosis treatment after hip fracture. It references a study by S. R. Majumdar et al., published on a 2007 issue of the journal "Archives of Internal Medicine." The study found that the proactive use of a case...

  • Continuing Bisphosphonate Treatment for Osteoporosis � For Whom and for How Long? Black, Dennis M.; Bauer, Douglas C.; Schwartz, Ann V.; Cummings, Steven R.; Rosen, Clifford J. // New England Journal of Medicine;5/31/2012, Vol. 366 Issue 22, p2051 

    The article discusses a study which reevaluated the efficacy of continuing bisphosphonate therapy beyond three to five years, by Whitaker and colleagues, published within the issue. The study examined the effect of long-term bisphosphonate use in reducing the risk of fractures. The authors...

  • Computational simulation of mechanical microenvironment of early stage of bone healing under locking compression plate with dynamic locking screws. Miramini, Saeed; Lihai Zhang; Richardson, Martin; Mendis, Priyan // Applied Mechanics & Materials;2014, Issue 553, p281 

    It is well known that bone healing outcomes highly depend on the mechanical microenvironment of the fracture site, and a certain degree of interfragmentary movement (IFM) is essential for indirect (i.e. natural) bone healing. The application of locking compression plate (LCP) internal fixation...

  • Reconstruction after Bone Healing Problems in Humeral Shaft Fractures. Sárváry, András Mária; Feczkó, Jozsef // European Journal of Trauma;Dec2003, Vol. 29 Issue 6, p356 

    Background: Categorization and therapy of bone healing disturbances of diaphyseal humeral fractures vary in the literature. Patients and Methods: A consecutive series of 25 revisions for bone healing disturbances was reviewed retrospectively. Timing of revisions, characteristics of delayed...

  • Evolving Data about Subtrochanteric Fractures and Bisphosphonates. Shane, Elizabeth // New England Journal of Medicine;5/13/2010, Vol. 362 Issue 19, p1825 

    In this article, the author expresses her views on data related to subtrochanteric fractures and bisphosphonates, in relation to a study published in a May 2010 issue of the "New England Journal of Medicine." She explains the ability of bisphosphonates to reduce bone turnover markers and...

  • Oral bisphosphonates in a postmenopausal population: a systemic review study. Chia-Chi Chu; Hirofumi Haga // Open Access Surgery;2013, Vol. 6, p37 

    Background: Osteoporosis is a debilitating disease that contributes to 1.5 million fractures per annum among women in the USA. The aim of this systemic review study was to determine the effects of oral bisphosphonates in preventing osteoporotic fractures in postmenopausal women. Methods: A...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics